Acta Scientific Clinical Oncology (ASCO) is an international, double- blinded peer-reviewed, highly viewed open access journal with a good impact factor that invites contributions of original and novel fundamental research on all aspects of developments of types of malignancies including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment.
We welcome you to submit your complete, valuable and reliable articles towards the journal at firstname.lastname@example.org
Internationally profound journal that Publishes articles on various disciplines of Ophthalmology.
Thorough Double blinded peer review.
Prompt Acknowledgement after acceptance of article for peer review.
Rapid Publication after the article is peer reviewed through eminent reviewers.
Acceptance and Publication of papers with excellence, novelty and originality.
Issue of Publication Certificate to author.
We Provide High visibility of your Published work.
Cancer is the most leading cause of death all around the world. The journal tries to aim at reducing the number of deaths from cancer with the help of eminent research findings from researcher.
Major subject areas of interest in Oncology include, but are not restricted to the accompanying fields:
The journal Clinical Oncology is dedicated to publish highly standard articles related to various cancers like Bladder Cancer, Brain Cancer, Breast Cancer, Colorectal Cancer, Genomic Cancer, Head and Neck cancer, HPV and Cervical Cancer, Lung Cancer, Liver Cancer, Melanoma, Metastatic Breast Cancer, Non-colorectal Gastrointestinal Cancer, Prostate Cancer, Renal Cell Carcinoma, Skin Cancer, Testicular cancer, Ovarian Cancer, Benign tumours, Cancer Chemotherapy, Pediatric oncology, Cancer prevention, Recent developments in tumor therapy, Radiation oncology, Veterinary and Comparative oncology, Clinical trials in oncology, Cancer nanotechnology, Carcinoma, Sarcoma, Myeloma, Leukemia, Lymphoma, Osteosarcoma or Osteogenic sarcoma, Chondrosarcoma, Leiomyosarcoma, Rhabdomyosarcoma, Mesothelial sarcoma or mesothelioma, Fibrosarcoma, Angiosarcoma, Liposarcoma, Glioma or Astrocytoma, Mesenchymous or Mixed mesodermal tumor, Genomic Medicine, Haematology. The main motto of the journal is to act as a mediator at making the scientific information reach the research community. So, we welcome Scientists, Research Scholars, Physicians and students in respective fields to put their informative works in the form of Research Article, Review Article, Short communication, Commentary, Opinion, Perspective, Case-Reports etc in the journal.